Cystic fibrosis (disorder)
Cystic Fibrosis Collection
Year Started: 2020
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- In progress
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Clinical records | 0 - 3 months |
| Freezer temperature logs | 0 - 3 months |
| Treatment records | 0 - 3 months |
Male
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | Not applicable | 100% | ||
| Whole blood | -60°C to -85°C | Not applicable | 100% |
Female
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Serum | -60°C to -85°C | Not applicable | 100% | ||
| Whole blood | -60°C to -85°C | Not applicable | 100% |
Acute myeloid leukemia, disease (disorder)
AML 10 Clinical Trial Collection
Year Started: 1992
Samples from the AML 10 Clinical Trial
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Male
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Primary cells | Liquid nitrogen vapor phase | Not applicable | 100% |
Acute myeloid leukemia, disease (disorder)
AML 12 Clinical Trial Collection
Year Started: 1995
Samples from the AML12 Clinical Trial
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| There is no associated data for this collection. | |
Female
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen vapor phase | Not applicable | 26 - 50% | ||
| Primary cells | Liquid nitrogen vapor phase | Not applicable | 51 - 75% |
Acute myeloid leukemia, disease (disorder)
AML 15 Clinical Trial Collection
Year Started: 2002
Samples from the AML 15 Clinical Trial
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- Other animal work restriction, Xenograft restriction
| Associated Data Type | Procurement Timeframe |
|---|---|
| Clinical records | 3 - 6 months |
| Followup records | 3 - 6 months |
| Treatment records | 3 - 6 months |
Male
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen vapor phase | Not applicable | 100% |
Acute myeloid leukemia, disease (disorder)
AML 17 Clinical Trial Collection
Year Started: 2007
Samples from the AML 17 trial
- Access:
- Open to applicants
- Type:
- Disease specific
- Status:
- Completed
- Consent restrictions:
- No restrictions
| Associated Data Type | Procurement Timeframe |
|---|---|
| Clinical records | 3 - 6 months |
| Followup records | 3 - 6 months |
| Treatment records | 3 - 6 months |
Unknown
Adolescent (12 - 18 years)
1 - 10 donors
| Material Type | Extraction Procedure | Storage Temperature | Preservation Type | Macroscopic Assessment | % of Sample Set |
|---|---|---|---|---|---|
| Peripheral blood mononuclear cells (PBMC) | Liquid nitrogen vapor phase | Not applicable | 100% |